Similar articles

• Brief review: rivastigmine, a second cholinesterase inhibitor.

  Patterson C, Hogan DB. Patterson C, et al. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S122-3. doi: 10.1017/s0317167100001293. Can J Neurol Sci. 2001. PMID: 11237306 Review. No abstract available.
• [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].

  Moerkens RM, Dhondt AD. Moerkens RM, et al. Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):679; author reply 679. Ned Tijdschr Geneeskd. 2003. PMID: 12712654 Dutch. No abstract available.
• [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].

  Mol JA. Mol JA. Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):679; author reply 679. Ned Tijdschr Geneeskd. 2003. PMID: 12712655 Dutch. No abstract available.
• [Acetylcholinesterase inhibitors for dementia--an update].

  Anghelescu I, Heuser I. Anghelescu I, et al. MMW Fortschr Med. 2007 May 21;149 Suppl 2:76-8. MMW Fortschr Med. 2007. PMID: 17724973 Review. German.
• [Treatment of degenerative dementia disorders--who should be treated?].

  Hasselbalch SG, Kampmann JP. Hasselbalch SG, et al. Ugeskr Laeger. 2009 Mar 2;171(10):802-5. Ugeskr Laeger. 2009. PMID: 19265606 Danish.